Effect of genetic background on onset and disease progression in the SOD1-G93A model of amyotrophic lateral sclerosis

被引:46
|
作者
Mancuso, Renzo [2 ,3 ]
Olivan, Sara [4 ]
Mancera, Pilar [5 ]
Pasten-Zamorano, Andrea [5 ]
Manzano, Raquel [4 ]
Casas, Caty [2 ,3 ]
Osta, Rosario [4 ]
Navarro, Xavier [1 ,2 ,3 ]
机构
[1] Univ Autonoma Barcelona, Fac Med, Unitat Fisiol Med, Grp Neuroplast & Regenerat,Inst Neurosci, E-08193 Bellaterra, Spain
[2] Univ Autonoma Barcelona, Dept Cell Biol Physiol & Immunol, E-08193 Bellaterra, Spain
[3] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Bellaterra, Spain
[4] Univ Zaragoza, Aragon Inst Hlth Sci, Lab Genet Biochem LAGENBIO I3A, Zaragoza, Spain
[5] Bioincubadora PCB Santander, Neurotec Pharma SL, Barcelona, Spain
来源
AMYOTROPHIC LATERAL SCLEROSIS | 2012年 / 13卷 / 03期
关键词
Motor neuron disease; neurodegeneration; SOD1-G93A mouse; background; animal model; TRANSGENIC MOUSE MODEL; SUPEROXIDE-DISMUTASE; HEXANUCLEOTIDE REPEAT; ALS; SURVIVAL; MICE; MUTATIONS; NEUROINFLAMMATION; EPIDEMIOLOGY; DEGENERATION;
D O I
10.3109/17482968.2012.662688
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Knowledge of the potential effect of genetic background in disease models is important. The SOD1-G93A transgenic mouse is the most widely used model in amyotrophic lateral sclerosis (ALS). Since these animals show considerable variability both in the onset and the progression of the disease, this study aimed to characterize the potential differences between the two most widely used strains, C56BL/6 (B6) and B6SJL. A rotarod test was carried out to assess strength and motor coordination, while electrophysiology tests were performed to evaluate the function of upper and lower motor neurons. Survival of the animals and motor neuron loss were also studied. The results did not show any background effect regarding the rotarod test, despite the differences in the pattern of decline in central and peripheral motor conduction. The onset of motor neuron abnormalities was later in B6SJL mice, but progressed more rapidly. Lifespan was longer for B6 than for B6SJL animals. In conclusion, background differences in disease onset and progression are important. The characteristics of the strain should be taken into account in experimental design of therapeutic studies.
引用
收藏
页码:302 / 310
页数:9
相关论文
共 50 条
  • [1] Sensory involvement in the SOD1-G93A mouse model of amyotrophic lateral sclerosis
    Yan-Su Guo
    Dong-Xia Wu
    Hong-Ran Wu
    Shu-Yu Wu
    Cheng Yang
    Bin Li
    Hui Bu
    Yue-sheng Zhang
    Chun-Yan Li
    Experimental & Molecular Medicine, 2009, 41 : 140 - 150
  • [2] Sensory involvement in the SOD1-G93A mouse model of amyotrophic lateral sclerosis
    Guo, Yan-Su
    Wu, Dong-Xia
    Wu, Hong-Ran
    Wu, Shu-Yu
    Yang, Cheng
    Li, Bin
    Bu, Hui
    Zhang, Yue-sheng
    Li, Chun-Yan
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2009, 41 (03): : 140 - 150
  • [3] Role of CDNF in SOD1-G93A Mouse Model of Amyotrophic Lateral Sclerosis
    Voutilainen, M. H.
    De Lorenzo, F.
    Montonen, E.
    Tuominen, R. K.
    Lindholm, D.
    Sendtner, M.
    Saarma, M.
    CELL TRANSPLANTATION, 2018, 27 (04) : 717 - 718
  • [4] Repurposing carbamazepine for the treatment of amyotrophic lateral sclerosis in SOD1-G93A mouse model
    Zhang, Jing-Jing
    Zhou, Qin-Ming
    Chen, Sheng
    Le, Wei-Dong
    CNS NEUROSCIENCE & THERAPEUTICS, 2018, 24 (12) : 1163 - 1174
  • [5] Targeting autotaxin impacts disease advance in the SOD1-G93A mouse model of amyotrophic lateral sclerosis
    Gento-Caro, Angela
    Vilches-Herrando, Esther
    Portillo, Federico
    Gonzalez-Forero, David
    Moreno-Lopez, Bernardo
    BRAIN PATHOLOGY, 2022, 32 (03)
  • [6] Neuroprotective Effects of Genistein in a SOD1-G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis
    Zhao, Zichun
    Fu, Jinsheng
    Li, Shiping
    Li, Zhenzhong
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2019, 14 (04) : 688 - 696
  • [7] Blood pressure measurements in a transgenic SOD1-G93A mouse model of amyotrophic lateral sclerosis
    Kandinov, Boris
    Drory, Vivian E.
    Tordjman, Karen
    Korczyn, Amos D.
    AMYOTROPHIC LATERAL SCLEROSIS, 2012, 13 (06): : 509 - 513
  • [8] Neuroprotective Effects of Genistein in a SOD1-G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis
    Zichun Zhao
    Jinsheng Fu
    Shiping Li
    Zhenzhong Li
    Journal of Neuroimmune Pharmacology, 2019, 14 : 688 - 696
  • [9] Neuroprotective effects of diallyl trisulfide in SOD1-G93A transgenic mouse model of amyotrophic lateral sclerosis
    Guo, Yansu
    Zhang, Kunxi
    Wang, Qian
    Li, Zhongyao
    Yin, Yunxia
    Xu, Qingmei
    Duan, Weisong
    Li, Chunyan
    BRAIN RESEARCH, 2011, 1374 : 110 - 115
  • [10] Immunohistochemical analysis of sympathetic involvement in the SOD1-G93A transgenic mouse model of amyotrophic lateral sclerosis
    Kandinov, Boris
    Grigoriadis, Nikolaos C.
    Touloumi, Olga
    Drory, Vivian E.
    Offen, Daniel
    Korczyn, Amos D.
    AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2013, 14 (5-6) : 424 - 433